Antimicrobial use in European acute care hospitals: results from the second point prevalence survey of healthcare-associated infections and antimicrobial use, 2016-2017
Antimicrobials are commonly used in acute care hospitals for the treatment of both community-acquired and healthcare-associated infections (HAIs), and for surgical prophylaxis. Studies have indicated that some antimicrobial use may be unnecessary and in instances when use is required, the selection, dose, route of administration and duration of treatment may be inappropriate. Through selection pressure, antimicrobials contribute to the emergence and spread of antimicrobial resistance (AMR).
Prevalence of healthcare-associated infections, estimated incidence, and composite antimicrobial resistance index in acute care hospitals and long-term care facilities: results from two European point prevalence surveys, 2016-2017
In the period from 2016 to 2017, ECDC organised two point prevalence surveys (PPS) of healthcare-associated infections (HAI) and antimicrobial use: the second PPS in acute care hospitals (ACH) and the third PPS in long-term care facilities (LTCF) in the EU/EEA. The objective of the current study was to report on the HAI and antimicrobial resistance results of both surveys and to estimate the combined total number of HAI on any given day and the number of HAI per year in 2016 and 2017 in the EU/EEA.
Antimicrobial resistance. Tackling the burden in the European Union. OECD and ECDC, 2019
The OECD, in collaboration with ECDC, has produced a briefing note on antimicrobial resistance (AMR) in the European Union and the European Economic Area. It presents key estimates of the health and economic impact of AMR and effective strategies to address this major public health threat.